4.5 Article

The Co(II), Ni(II), Cu(II) and Zn(II) complexes of aroylhydrazone of quinolone core: Syntheses, characterization and evaluation of antimicrobial and antitubercular activity

期刊

INORGANICA CHIMICA ACTA
卷 522, 期 -, 页码 -

出版社

ELSEVIER SCIENCE SA
DOI: 10.1016/j.ica.2021.120352

关键词

Quinolone; Antimicrobial; Antituberculosis; Single-crystal X-ray diffraction

资金

  1. University Grants Commission, New Delhi (U.G.C.) [MRP(S)-0475/13-14/KAKA089/UGC-SWRO]

向作者/读者索取更多资源

A series of ligand 3,5-di-tert-butyl-2-hydroxy-N?-((2-oxo-1,2-dihydroquinolin-3-yl)methylene)benzohydrazide and its metal complexes were synthesized and characterized using various techniques. The copper(II) complex showed the best antimicrobial activity, particularly against gram-positive S. Aureus.
The ligand 3,5-di-tert-butyl-2-hydroxy-N?-((2-oxo-1,2-dihydroquinolin-3-yl)methylene)benzohydrazide (H2L) and its Co(II), Ni(II), Cu(II), Zn(II) complexes were synthesized. The ligand and its complexes were characterized by various spectro-analytical techniques including IR, 1H NMR, 13C NMR, EPR, electronic spectroscopy, and elemental analysis. In addition, the molecular structures of H2L, [CoII(HL)2] (1), [NiII(HL)2] (2), [CuII(HL)(Cl) (CH3OH)] (3), and [CuII(HL)(H2O)(CH3OH)].ClO4 (4) were unambiguously established using single-crystal X-ray structure determination. However, the Zn(II) complex was characterized based on the IR, NMR and elemental analysis and the 6-coordinate with a 1:2 (M:L) ratio was proposed with the molecular formula [ZnII(HL)2)] (5). The synthesized compounds were investigated for antimicrobial and antitubercular activities. The copper(II) complex 4, has shown the lowest MIC of 0.4 ?g/mL, against the gram-positive S. Aureus microorganism, which was better than the ligand and the standard Ciprofloxacin drug. Except for the complex 3, the ligand and rest of its complexes exhibited better activity against gram-negative, E. Coli with the MIC values ranging from 0.4 - 0.8 ?g/ mL and were much better than the standard Ciprofloxacin drug

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据